[go: up one dir, main page]

GB0417302D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0417302D0
GB0417302D0 GB0417302A GB0417302A GB0417302D0 GB 0417302 D0 GB0417302 D0 GB 0417302D0 GB 0417302 A GB0417302 A GB 0417302A GB 0417302 A GB0417302 A GB 0417302A GB 0417302 D0 GB0417302 D0 GB 0417302D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0417302A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0417302A priority Critical patent/GB0417302D0/en
Publication of GB0417302D0 publication Critical patent/GB0417302D0/en
Priority to PE2005000884A priority patent/PE20060560A1/en
Priority to ARP050103199A priority patent/AR050044A1/en
Priority to SI200531872T priority patent/SI1817343T1/en
Priority to TW094126210A priority patent/TWI356828B/en
Priority to CN2005800260794A priority patent/CN101001877B/en
Priority to SG200905152-5A priority patent/SG155177A1/en
Priority to PT57698383T priority patent/PT1817343E/en
Priority to DK05769838.3T priority patent/DK1817343T3/en
Priority to ES05769838.3T priority patent/ES2504415T3/en
Priority to PL05769838T priority patent/PL1817343T3/en
Priority to PCT/EP2005/008361 priority patent/WO2006013087A1/en
Priority to EP10180854A priority patent/EP2327726A3/en
Priority to EP05769838.3A priority patent/EP1817343B1/en
Priority to US11/632,939 priority patent/US7740843B2/en
Priority to KR1020077002715A priority patent/KR101245996B1/en
Priority to MYPI20053585A priority patent/MY141851A/en
Priority to RU2007107849/13A priority patent/RU2382049C2/en
Priority to JP2007524263A priority patent/JP4808712B2/en
Priority to AU2005268932A priority patent/AU2005268932B2/en
Priority to NZ552637A priority patent/NZ552637A/en
Priority to MX2007001342A priority patent/MX2007001342A/en
Priority to BRPI0514124A priority patent/BRPI0514124B8/en
Priority to CA2574289A priority patent/CA2574289C/en
Priority to IL180789A priority patent/IL180789A/en
Priority to EC2007007222A priority patent/ECSP077222A/en
Priority to TNP2007000036A priority patent/TNSN07036A1/en
Priority to NO20070854A priority patent/NO20070854L/en
Priority to MA29708A priority patent/MA28981B1/en
Priority to HK07114047.7A priority patent/HK1109158A1/en
Priority to US12/760,891 priority patent/US20100254993A1/en
Priority to CY20141100716T priority patent/CY1115524T1/en
Priority to HRP20140888TT priority patent/HRP20140888T1/en
Ceased legal-status Critical Current

Links

GB0417302A 2004-08-03 2004-08-03 Organic compounds Ceased GB0417302D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB0417302A GB0417302D0 (en) 2004-08-03 2004-08-03 Organic compounds
PE2005000884A PE20060560A1 (en) 2004-08-03 2005-08-01 HUMAN INTERLEUKIN-4 ANTIBODIES
ARP050103199A AR050044A1 (en) 2004-08-03 2005-08-01 IL-4 SPECIFIC ANTIBODY
CA2574289A CA2574289C (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human il-4
MYPI20053585A MY141851A (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human il-4
JP2007524263A JP4808712B2 (en) 2004-08-03 2005-08-02 Human monoclonal antibody against human IL-4
CN2005800260794A CN101001877B (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human IL-4
SG200905152-5A SG155177A1 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human il-4
PT57698383T PT1817343E (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human il-4
DK05769838.3T DK1817343T3 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies to human IL-4
ES05769838.3T ES2504415T3 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human IL-4
PL05769838T PL1817343T3 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human il-4
PCT/EP2005/008361 WO2006013087A1 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human il-4
EP10180854A EP2327726A3 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human IL-4
EP05769838.3A EP1817343B1 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human il-4
US11/632,939 US7740843B2 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human IL-4
KR1020077002715A KR101245996B1 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human il-4
SI200531872T SI1817343T1 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human il-4
RU2007107849/13A RU2382049C2 (en) 2004-08-03 2005-08-02 HUMAN MONOCLONAL ANTIBODIES TO HUMAN INTERLEUKINE-4 (hIL-4)
TW094126210A TWI356828B (en) 2004-08-03 2005-08-02 Human il-4 specific antibodies and relevant polynu
AU2005268932A AU2005268932B2 (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human IL-4
NZ552637A NZ552637A (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human IL-4
MX2007001342A MX2007001342A (en) 2004-08-03 2005-08-02 Human monoclonal antibodies against human il-4.
BRPI0514124A BRPI0514124B8 (en) 2004-08-03 2005-08-02 monoclonal antibodies specific for human il-4, their use, pharmaceutical composition comprising them, and polynucleotides
IL180789A IL180789A (en) 2004-08-03 2007-01-18 Human monoclonal antibodies against human il-4
EC2007007222A ECSP077222A (en) 2004-08-03 2007-02-02 HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUCINE-4 (IL-4)
TNP2007000036A TNSN07036A1 (en) 2004-08-03 2007-02-02 Human monoclonal antibodies against human il-4
NO20070854A NO20070854L (en) 2004-08-03 2007-02-14 Human monoclonal antibodies to human IL-4.
MA29708A MA28981B1 (en) 2004-08-03 2007-02-22 HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN IL-4
HK07114047.7A HK1109158A1 (en) 2004-08-03 2007-12-21 Human monoclonal antibodies against human il-4 il-4
US12/760,891 US20100254993A1 (en) 2004-08-03 2010-04-15 Human monoclonal antibodies against human il-4
CY20141100716T CY1115524T1 (en) 2004-08-03 2014-09-05 HUMAN MONOCLONIC ANTIBODIES AGAINST HUMAN IL-4
HRP20140888TT HRP20140888T1 (en) 2004-08-03 2014-09-17 Human monoclonal antibodies against human il-4

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0417302A GB0417302D0 (en) 2004-08-03 2004-08-03 Organic compounds

Publications (1)

Publication Number Publication Date
GB0417302D0 true GB0417302D0 (en) 2004-09-08

Family

ID=32982464

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0417302A Ceased GB0417302D0 (en) 2004-08-03 2004-08-03 Organic compounds

Country Status (1)

Country Link
GB (1) GB0417302D0 (en)

Similar Documents

Publication Publication Date Title
GB0409921D0 (en) Organic compounds
GB0403038D0 (en) Organic compounds
GB0407723D0 (en) Organic compounds
GB0405289D0 (en) Organic compounds
GB0401334D0 (en) Organic compounds
GB0402797D0 (en) Organic compounds
GB0404434D0 (en) Organic compounds
GB0408078D0 (en) Organic compounds
GB0400781D0 (en) Organic compounds
GB0403115D0 (en) Organic compounds
GB0406515D0 (en) Organic compounds
GB0403254D0 (en) Organic compounds
GB0405723D0 (en) Organic compounds
GB0409236D0 (en) Organic compounds
GB0406240D0 (en) Organic compounds
GB0405898D0 (en) Organic compounds
GB0407468D0 (en) Organic compounds
GB0407607D0 (en) Organic compounds
GB0405034D0 (en) Organic compounds
GB0402100D0 (en) Organic compounds
GB0406737D0 (en) Organic compounds
GB0403964D0 (en) Organic compounds
GB0402682D0 (en) Organic compounds
GB0417302D0 (en) Organic compounds
GB0401867D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)